Stabilization of Transcription Factor, HIF-1α by Prolylhydroxylase 1 Knockout Reduces Cardiac Injury After Myocardial

Mahesh Thirunavukkarasu1, Seetur R Pradeep1, Babatunde Oriowo1

  • 1Molecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut School of Medicine, UConn Health, Farmington, CT 06030, USA.

Cells
|March 26, 2025
PubMed

Insights

PHD1 knockout in mice enhances blood vessel formation and improves heart function after myocardial infarction. This study highlights PHD1 inhibition as a potential therapeutic strategy for heart attack recovery.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Hypoxia Signaling

Background:

  • Hypoxia-inducible factors (HIFs) regulate cellular responses to low oxygen and ischemic conditions.
  • Prolyl hydroxylase domain (PHD) enzymes, including PHD1, regulate HIF stability.
  • Investigating PHD1's role in myocardial infarction (MI) may reveal new therapeutic targets.

Purpose of the Study:

  • To investigate the cardioprotective effects of PHD1 knockout against myocardial infarction in a mouse model.
  • To analyze the impact of PHD1 deficiency on cardiac function, angiogenesis, and gene expression post-MI.

Main Methods:

  • Myocardial infarction was induced via left anterior descending coronary artery ligation in wild-type and PHD1 knockout mice.
  • Cardiac function was assessed using echocardiography.
  • Vessel density, HIF-1α DNA binding activity, protein expression (HSPA12B), and gene expression (microarray) were analyzed.

Main Results:

  • PHD1 knockout mice exhibited significantly increased capillary and arteriolar density post-MI.
  • Echocardiography revealed improved ejection fraction and fractional shortening in PHD1 knockout mice 30 days post-MI.
  • Increased HIF-1α DNA binding activity and HSPA12B expression were observed in PHD1 knockout mice post-MI.

Conclusions:

  • PHD1 knockout promotes angiogenesis and enhances cardioprotection following myocardial infarction.
  • The findings suggest that inhibiting PHD1 activates protective molecular pathways, improving cardiac recovery.